Amid its ongoing efforts to support the biotech industry, and repeated calls from the industry, South Korea is aiming to introduce fast-track review and approval systems for cutting-edge biologics and medical devices in December 2018, a move that is expected to help provide timely patient access to more treatment options and speed up the global entry of domestic companies.
Korea To Introduce Fast-Track Review For Cutting-Edge Biologics, Devices
South Korea is set to adopt fast-track review systems for cutting-edge biologics and medical devices late this year as it continues to nurture the biotech industry and in line with global trends